Agile Therapeutics Inc., a women's health specialty pharmaceutical company, on Monday announced active recruitment has closed in its ongoing single-arm, open-label Phase 3 SECURE clinical trial of Twirla, its investigational contraceptive patch. Read More »

Titan Pharmaceuticals Inc. on Monday announced the resubmission by Braeburn Pharmaceuticals of a New Drug Application to the U.S. Food and Drug Administration for Probuphine. Read More »

Advaxis Inc. announced on Tuesday that its final clinical data from Stage 1 of the ongoing two-stage Phase 2 study of axalimogene filolisba in patients with persistent or recurrent metastatic carcinoma of the cervix will be presented at the American Gynecological & Obstetrical Society's annual meeting. Read More »

Trial to test SGX942, a first-in-class innate defense regulator for use with head and neck cancers. Read More »

Valeant Pharmaceuticals International, Inc. announced Tuesday the addition of D. Robert Hale, partner of ValueAct Capital, to its board of directors and the resignation of Jeffrey W. Ubben, CEO and CIO of ValueAct Capital, effective as of Aug. 19. Read More »

Amneal said on Tuesday that it has created Amneal Biosciences, a wholly owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals, such as injectables, oncologics and biosimilars. Read More »

Lawmakers tour Wedgewood Pharmacy's Swedesboro, New Jersey facilities. Read More »

Armada to continue to sell and market Alferon N Injection, the FDA-approved natural interferon Read More »

Specialty Pharmacy Times said Monday that it has added five specialty pharmacies in an expansion of its Strategic Alliance Partnership program.The alliances will assist the collaboration and sharing of knowledge among partners, as well as increase the industrywide visibility of participating pharmacy organizations. Read More »

Allergan, a global pharmaceutical company, announced Monday it has completed the acquisition of Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease. Under the terms of the agreement, Allergan is acquiring Oculeve for a $125 million upfront payment and commercialization milestone payments related to Oculeve's lead development program, OD-01. Read More »

Pharmacy Times and U.S. News & World Report honored Cetaphil as the No. 1 Pharmacist Recommended brand in the Therapeutic Skin Care Cleansers category for the third year in a row, Cetaphil said on Thursday. Read More »

After long wait, FDA finally approves drug for use in the U.S. Read More »

Prime Aid Pharmacy was recently awarded both URAC Specialty Pharmacy and Mail Order Pharmacy accreditation. Read More »

URAC accreditation process serves as a basis to improve business processes Read More »

If approved, Praluent would be first fully human monoclonal antibody targeting PCSK9 in U.S. Read More »

Companies to move Lycera's exclusive pipeline for cancer and immune-mediated diseases forward. Read More »

Specialty Pharmacy Times and the National Association of Specialty Pharmacy (NASP) are partnering to better equip pharmacy businesses and clinicians amidst the growing number of complex medicines. Read More »

Inside Pharmacy, a journal that compiles pertinent information such as clinical, business and regulatory issues for nurse practitioners, physician's assistants and pharmacy managers, was recently introduced by The Lynx Group. Read More »

Armada Health Care on Thursday announced it is launching an integrated, web-based software platform that enhances specialty pharmacy operations, prescription workflow and overall patient management. Read More »

Actavis confirmed last week that it has filed an abbreviated new drug application with the U.S. Food and Drug Administration (FDA), requesting approval to market Ambrisentan, and has confirmed a patent challenge. Read More »